Liquid Phase Peptide Synthesis Industry - Regional Synopsis
North American Market Forecast
North America industry is predicted to dominate majority revenue share of 42% by 2037. The North American market stands as a prominent hub in the global landscape due to several key factors. Fueled by robust research and development activities, the region witnesses extensive utilization of peptides in drug discovery and development by pharmaceutical giants and biotechnology firms. In 2021, research and development expenditure in the United States pharmaceuticals industry amounted to around USD 102 billion. With a strong presence of cutting-edge technology and state-of-the-art infrastructure, North America showcases a significant market share in Liquid Phase Peptide Synthesis.
APAC Market Statistics
Asia Pacific region is also poised to garner significant revenue share, the Asia Pacific liquid phase peptide synthesis market is experiencing substantial growth attributed to several key factors. Rapid economic development, coupled with increasing healthcare expenditure across countries like China, India, Japan, South Korea, and others, is driving the market’s expansion. The region’s pharmaceutical industry is witnessing remarkable advancements, fostering a conducive environment for peptide synthesis technologies. Additionally, the escalating prevalence of chronic diseases and the growing demand for innovative therapeutic solutions fuel the adoption of liquid-phase peptide synthesis in drug discovery and development within the Asia Pacific.
